Life-threatening asthma: Pathophysiology and management

Respiratory Care

Volumn 53, Issue 6, 2008, Pages 726-735

  Lugogo, Njira L ^a   MacIntyre, Neil R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Airway inflammation; Asthma; Bronchodilators; Corticosteroids; Exacerbation; Fatal asthma; Mechanical ventilation; Respiratory failure

Indexed keywords

ADRENALIN; AMINOPHYLLINE; ANESTHETIC AGENT; ATRACURIUM; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FORMOTEROL; HELIUM; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MAGNESIUM SULFATE; METHYLPREDNISOLONE; NITRIC OXIDE; OXYGEN; PANCURONIUM; PEPTIDOLEUKOTRIENE; PREDNISONE; SALBUTAMOL; THEOPHYLLINE; VECURONIUM; ZAFIRLUKAST;

ACUTE DISEASE; ACUTE HEART INFARCTION; AIRWAY OBSTRUCTION; ANESTHESIA; ARTERIAL GAS; ARTERIAL OXYGEN SATURATION; ARTIFICIAL VENTILATION; ASPHYXIA; ASTHMA; ASTHMATIC STATE; BLOOD GAS ANALYSIS; BRONCHITIS; BRONCHOSPASM; CAPNOGRAPHY; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; EARLY DIAGNOSIS; FATALITY; FORCED EXPIRATORY VOLUME; HEALTH CARE PLANNING; HEALTH SURVEY; HEART ARRHYTHMIA; HUMAN; HYPOCAPNIA; LUNG COMPLIANCE; LUNG FUNCTION; LUNG VENTILATION; LUNG VOLUME; METERED DOSE INHALER; MORBIDITY; MORTALITY; NAUSEA; NEBULIZER; OUTCOME ASSESSMENT; OXYGEN THERAPY; PATHOPHYSIOLOGY; PEAK EXPIRATORY FLOW; PHENOTYPE; POPULATION RISK; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PROGNOSIS; SEDATION; SPIROMETRY; TACHYCARDIA; TREATMENT RESPONSE; TREMOR; VOMITING; ADOLESCENT; ADULT; ARTICLE; CHILD; ETHNOLOGY; FEMALE; HOSPITALIZATION; INFANT; MALE; PRESCHOOL CHILD; UNITED STATES;

ADOLESCENT; ADULT; ASTHMA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; RESPIRATION, ARTIFICIAL; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 54549083310     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (106)

1. Asthma prevalence, health care use, and mortality: United States, 2003-2005. National Health Interview Survey. National Center for Health Statistics. http://www.cdc.gov/nchs/products/pubs/pubd/hestats/ashtma03-05/ asthma03-05.htm. Accessed April 3, 2008.
2. Rowe BH, Edmonds ML, Spooner CH, Camargo CA. Evidence-based treatments for acute asthma. Respir Care 2001;46(12):1380-1390 (Pubitemid 33759922)
3. Watson L, Turk F, James P, Holgate ST. Factors associated with mortality after an asthma admission: a national United Kingdom database analysis. Respir Med 2007;101(8):1659-1664. (Pubitemid 46947879)
4. Griswold SK, Nordstrom CR, Clark S, Gaeta TJ, Price ML, Camargo CA Jr. Asthma exacerbations in North American adults: Who are the "frequent fliers" in the emergency department? Chest 2005;127(5):1579-1586.
5. Levy BD, Kitch B, Fanta CH. Medical and ventilatory management of status asthmaticus. Intensive Care Med 1998;24(2):105-117. (Pubitemid 28192090)
6. Lamblin C, Gosset P, Tillie-Leblond I, Saulnier F, Marquette CH, Wallaert B, Tonnel AB. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med 1998;157(2):394-402. (Pubitemid 28090526)
7. Tonnel AB, Gosset P, Tillie-Leblond I. Characteristics of the inflammatory response in bronchial lavage fluids from patients with status asthmaticus Int Arch Allergy Immunol 2001;124(1-3):267-271.
8. Tillie-Leblond I, Pugin J, Marquette CH, Lamblin C, Saulnier F, Brichet A, et al. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 1999;159(2):487-494. (Pubitemid 29084870)
9. Gleich GJ, Motojima S, Frigas E, Kephart GM Fujisawa T, Kravis LP. The eosinophilic leukocyte and the pathology of fatal bronchial asthma: evidence for pathologic heterogeneity. J Allergy Clin Immunol 1987;80(3 Pt 2):412-415. (Pubitemid 17135992)
10. Wenzel S. Severe asthma: epidemiology, pathophysiology and treatment. Mt Sinai J Med 2003;70(3):185-190 (Pubitemid 36575744)
11. Picado C. Classification of severe asthma exacerbations: a proposal. Eur Respir J 1996;9(9):1775-1778. (Pubitemid 26294743)
12. Ramnath VR, Clark S, Camargo CA Jr. Multicenter study of clinical features of sudden-onset versus slower-onset asthma exacerbations requiring hospitalization Respir Care 2007;52(8):1013-1020.
13. Barr RG, Woodruff PG, Clark S, Camargo CA Jr. Sudden-onset asthma exacerbations: clinical features, response to therapy, and 2-week follow-up. Multicenter Airway Research Collaboration (MARC) investigators. Eur Respir J 2000;15(2):266-273. (Pubitemid 30085951)
14. Wasserfallen JB, Schaller MD, Feihl F, Perret CH. Sudden asphyxic asthma: a distinct entity? Am Rev Respir Dis 1990;142(1):108-111.
15. Huber HL. The pathology of bronchial asthma. Arch Intern Med 1922;30(6):689-760.
16. Dhuper S, Maggiore D, Chung V, Shim C. Profile of near-fatal asthma in an inner-city hospital. Chest 2003;124(5):1880-1884. (Pubitemid 37433587)
17. Romagnoli M, Caramori G, Braccioni F, Ravenna F, Barreiro E, Siafakas NM, et al. Near-fatal asthma phenotype in the ENFU-MOSA Cohort. Clin Exp Allergy 2007;37(4):552-557. (Pubitemid 46537743)
18. Barnard A. Management of an acute asthma attack. Aust Fam Physician 2005;34(7):531-534.
19. Molfino NA, Slutsky AS. Near-fatal asthma. Eur Respir J 1994;7(5):981-990. (Pubitemid 24153601)
20. Aldington S, Beasley R. Asthma exacerbations. 5: Assessment and management of severe asthma in adults in hospital. Thorax 2007;62(5):447-458.
21. Osborne ML, Pedula KL, O'Hollaren M, Ettinger KM, Stibolt T, Buist AS, Vollmer WM. Assessing future need for acute care in adult asthmatics: The Profile of Asthma Risk Study: A prospective health maintenance organization-based study. Chest 2007;132(4):1151-1161. (Pubitemid 47620987)
22. Rubinfeld AR, Pain MC. Perception of asthma. Lancet 1976;1(7965):882-884.
23. McFadden ER Jr. Acute severe asthma Am J Respir Crit Care Med 2003;168(7):740-759.
24. Expert panel report 3: guidelines for the diagnosis and management of asthma. Bethesda, Maryland: National Institutes of Health, National Asthma Education and Prevention Program; 2007. NIH Publication No. 08-4051. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. Accessed April 1, 2008.
25. Cairns CB, Acute asthma exacerbations: phenotypes and management. Clin Chest Med 2006;27(1):99-108.
26. Neville E, Gribbin H, Harrison BD. Acute severe asthma. Respir Med 1991;85(6):463-474.
27. Rebuck AS, Read J. Assessment and management of severe asthma. Am J Med 1971;51(6):788-798.
28. Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults: a review. Chest 2004;125(3):1081-1102. (Pubitemid 38367305)
29. Silverman RA, Flaster E, Enright PL, Simonson SG. FEV1 performance among patients with acute asthma: results from a multicenter clinical trial. Chest 2007;131(1):164-171. (Pubitemid 46122989)
30. Rodrigo GJ, There are no excuses for not performing spirometry in acute asthmatics in the emergency department setting. Chest 2007;131(5):1615. (Pubitemid 46762383)
31. Corre KA, Rothstein RJ Assessing severity of adult asthma and need for hospitalization. Ann Emerg Med 1985;14(1):45-52. (Pubitemid 15161264)
32. Choi IS, Koh YI, Lim H. Peak expiratory flow rate underestimates severity of airflow obstruction in acute asthma. Korean J Intern Med 2002;17(3):174-179.
33. Higgins BG, Britton JR, Chinn S, Jones TD, Jenkinson D, Burney PG, Tattersfield AE. The distribution of peak expiratory flow variability in a population sample. Am Rev Respir Dis 1989;140(5):1368-1372. (Pubitemid 19276225)
34. Frischer T, Meinert R, Urbanek R, Kuehr J. Variability of peak expiratory flow rate in children: short and long term reproducibility. Thorax 1995;50(1):35-39.
35. Adkisson M, Kraft M. Peak flow does not accurately reflect airway resistance in adult patients with asthma. Ann Emerg Med 2000;36(4):8-9
36. Falliers CJ. Ventilatory impairment in asthma: perceptions vs measurements. Chest 1998;113(2):265-267. (Pubitemid 28109993)
37. Gelb AF, Flynn Taylor C, Shinar CM, Gutierrez C, Zamel N. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest 2006;129(6):1492-1499. (Pubitemid 43894977)
38. Harkins MS, Fiato KL, Iwamoto GK. Exhaled nitric oxide predicts asthma exacerbation. J Asthma 2004;41(4):471-476. (Pubitemid 38955405)
39. Katsara M, Donnelly D, Iqbal S, Elliott T, Everard ML. Relationship between exhaled nitric oxide levels and compliance with inhaled corticosteroids in asthmatic children. Respir Med 2006;100(9):1512-1517. (Pubitemid 44089370)
40. Shaw DE, Berry MA, Thomas M, Green RH, Brightling CE, Wardlaw AJ, Pavord ID. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med 2007;176(3):231-237. (Pubitemid 47195872)
41. Gill M, Walker S, Khan A, Green SM, Kim L, Gray S, Krauss B. Exhaled nitric oxide levels during acute asthma exacerbation. Acad Emerg Med 2005;12(7):579-586. (Pubitemid 40827127)
42. Kunkov S, Pinedo V, Silver EJ, Crain EF. Predicting the need for hospitalization in acute childhood asthma using end-tidal capnography. Pediatr Emerg Care 2005;21(9):574-577. (Pubitemid 41362213)
43. Yaron M, Padyk P, Hutsinpiller M, Cairns CB. Utility of the expiratory capnogram in the assessment of bronchospasm. Ann Emerg Med 1996;28(4):403-407. (Pubitemid 26327637)
44. Corbo J, Bijur P, Lahn M, Gallagher EJ. Concordance between capnography and arterial blood gas measurements of carbon dioxide in acute asthma. Ann Emerg Med 2005;46(4):323-327. (Pubitemid 41362561)
45. Ward KR, Yealy DM. End-tidal carbon dioxide monitoring in emergency medicine, Part 2: Clinical applications. Acad Emerg Med 1998;5(6):637-646.
46. Carruthers DM, Harrison BD. Arterial blood gas analysis or oxygen saturation in the assessment of acute asthma? Thorax 1995;50(2):186-188.
47. Boulet LP, Becker A, Bérubé D, Beveridge R, Ernst P. Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ 1999;161(11 Suppl):S1-S61.
48. Travers A, Jones AP, Kelly K, Barker SJ, Camargo CA, Rowe BH. Intravenous beta2-agonists for acute asthma in the emergency department. Cochrane Database Syst Rev 2001;(2):CD002988.
49. Newhouse MT. Emergency department management of life-threatening asthma. Are nebulizers obsolete? Chest 1993;103(3):661-663.
50. Idris AH, McDermott MF, Raucci JC, Morrabel A, McGorray S, Hendeles L. Emergency department treatment of severe asthma. Metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. Chest 1993;103(3):665-672.
51. Camargo CA Jr, Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists in the treatment of acute asthma. Cochrane Database Syst Rev 2003;(4):CD001115.
52. Najafizadeh K, Sohrab Pour H, Ghadyanee M, Shiehmorteza M, Jamali M, Majdzadeh S. A randomised, double-blind, placebo-controlled study to evaluate the role of formoterol in the management of acute asthma. Emerg Med J 2007;24(5):317-321. (Pubitemid 46696352)
53. Rubinfeld AR, Scicchitano R, Hunt A, Thompson PJ, Van Nooten A, Selroos O. Formoterol Turbuhaler as reliever medication in patients with acute asthma. Eur Respir J 2006;27(4):735-741. (Pubitemid 44914196)
54. Hospenthal MA, Peters JI. Long-acting beta(2)-agonists in the management of asthma exacerbations. Curr Opin Pulm Med 2005;11(1):69-73.
55. Munro A, Maconochie I. Best evidence topic reports. Beta-agonists with or without anti-cholinergics in the treatment of acute childhood asthma? Emerg Med J 2006;23(6):470.
56. Kanazawa H. Anticholinergic agents in asthma: chronic bronchodilator therapy, relief of acute severe asthma, reduction of chronic viral inflammation and prevention of airway remodeling. Curr Opin Pulm Med 2006;12(1):60-67. (Pubitemid 44378580)
57. 2-agonists? Am J Respir Med 2003;2(2):109-115.
58. Cunnington D, Smith N, Steed K, Rosengarten P, Kelly AM, Teichtahl H. Oral versus intravenous corticosteroids in adults hospitalised with acute asthma. Pulm Pharmacol Ther 2005;18(3):207-212. (Pubitemid 40222116)
59. Rowe BH, Keller JL, Oxman AD. Effectiveness of steroid therapy in acute exacerbations of asthma: a meta-analysis. Am J Emerg Med 1992;10(4):301-310.
60. Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev 2007;(3):CD000195. (Pubitemid 351805476)
61. Green SA, Malice MP, Tanaka W, Tozzi CA, Reiss TF. Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation. Thorax 2004;59(2):100-104. (Pubitemid 38223478)
62. Harmanci K, Bakirtas A, Turktas I, Degim T. Oral montelukast treatment of preschool-aged children with acute asthma. Ann Allergy Asthma Immunol 2006;96(5):731-735. (Pubitemid 43749007)
63. Kuitert LM, Watson D. Antileukotrienes as adjunctive therapy in acute asthma. Drugs 2007;67(12):1665-1670. (Pubitemid 47263176)
64. Silverman RA, Nowak RM, Korenblat PE, Skobeloff E, Chen Y, Bonuccelli CM, et al. Zafirlukast treatment for acute asthma: evaluation in a randomized, double-blind, multicenter trial. Chest 2004;126(5):1480-1489. (Pubitemid 39525020)
65. Camargo CA Jr, Smithline HA, Malice MP, Green SA, Reiss TF. A randomized controlled trial of intravenous montelukast in acute asthma Am J Respir Crit Care Med 2003;167(4):528-533.
66. Currie GP, Devereaux GS, Lee DK, Ayres JG. Recent developments in asthma management. BMJ 2005;330(7491):585-589. (Pubitemid 40380355)
67. Yamauchi K, Kobayashi H, Tanifuji Y, Yoshida T, Pian HD, Inoue H. Efficacy and safety of intravenous theophylline administration for treatment of mild acute exacerbation of bronchial asthma. Respirology 2005;10(4):491-496. (Pubitemid 43942619)
68. Roberts G, Newsom D, Gomez K, Raffles A, Saglani S, Begent J, et al. Intravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trial. Thorax 2003;58(4):306-310. (Pubitemid 36411415)
69. Mitra A, Bassler D, Goodman K, Lasserson TJ, Ducharme FM. Intravenous aminophylline for acute severe asthma in children over 2 years receiving inhaled bronchodilators. Cochrane Database Syst Rev 2005;(2):CD001276.
70. Siegel D, Sheppard D, Gelb A, Weinberg PF. Aminophylline increased the toxicity but not the efficacy of an inhaled beta-adrenergic agonist in the treatment of acute exacerbations of asthma. Am Rev Respir Dis 1985;132(2):283-286. (Pubitemid 15229381)
71. Wiebe K, Rowe BH. Nebulized racemic epinephrine used in the treatment of severe asthmatic exacerbation: a case report and literature review. CJEM 2007;9(4):304-308. (Pubitemid 47232901)
72. Adoun M, Frat JP, Doré P, Rouffineau J, Godet C, Robert R. Comparison of nebulized epinephrine and terbutaline in patients with acute severe asthma: a controlled trial. J Crit Care 2004;19(2):99-102. (Pubitemid 38953760)
73. Rowe BH, Camargo CA Jr. Emergency department treatment of severe acute asthma. Ann Emerg Med 2006;47(6):564-566.
74. Putland M, Kerr D, Kelly AM. Adverse events associated with the use of intravenous epinephrine in emergency department patients presenting with severe asthma. Ann Emerg Med 2006;47(6):559-563. (Pubitemid 43732513)
75. Smith D, Riel J, Tilles I, Kino R, Lis J, Hoffman JR. Intravenous epinephrine in life-threatening asthma. Ann Emerg Med 2003;41(5):706-711. (Pubitemid 36520251)
76. Cairns CB, Kraft M. Magnesium attenuates the neutrophil respiratory burst in adult asthmatic patients. Acad Emerg Med 1996;3(12):1093-1097. (Pubitemid 26415783)
77. Blitz M, Blitz S, Beasely R, Diner BM, Hughes R, Knopp JA, Rowe BH. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev 2005;(2):CD003898.
78. Thomson AJ, Webb DJ, Maxwell SR, Grant IS. Oxygen therapy in acute medical care. BMJ 2002;324(7351):1406-1407. (Pubitemid 34634226)
79. Chien JW, Ciufo R, Novak R, Skowronski M, Nelson J, Coreno A, McFadden ER Jr. Uncontrolled oxygen administration and respiratory failure in acute asthma. Chest 2000;117(3):728-733. (Pubitemid 30152212)
80. Downs JB, Smith RA. Increased inspired oxygen concentration may delay diagnosis and treatment of significant deterioration in pulmonary function. Crit Care Med 1999;27(12):2844-2846. (Pubitemid 30027218)
81. Hess DR. Heliox and inhaled nitric oxide. In: MacIntyre NR, Branson RD (editors). Mechanical Ventilation. WB Saunders, Philadelphia; 2001:454-480.
82. Colebourn CL, Barber V, Young JD. Use of helium-oxygen mixture in adult patients presenting with exacerbations of asthma and chronic obstructive pulmonary disease: a systematic review. Anaesthesia 2007;62(1):34-42. (Pubitemid 44869636)
83. Rodrigo G, Pollack C, Rodrigo C, Rowe BH. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev 2006;(4):CD002884.
84. Kim IK, Phrampus E, Benkataraman S, Pitetti R, Saville A, Corcoran T, et al. Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial. Pediatrics 2005;116(5):1127-1133. (Pubitemid 46056418)
85. Reuben AD, Harris AR. Heliox for asthma in the emergency department: a review of the literature. Emerg Med J 2004;21(2):131-135. (Pubitemid 38344621)
86. Ho AM, Lee A, Karmakar MK, Dion PW, Chung DC, Contardi LH. Heliox vs air-oxygen mixtures for the treatment of patients with acute asthma: a systematic overview. Chest 2003;123(3):882-890. (Pubitemid 36315507)
87. Jacobs M, Reid C, Butler J. Best evidence topic report. Use of heliox for acute asthma in the emergency department. Emerg Med J 2004;21(4):498-499
88. Johnson KH. Heliox of minimal benefit in acute asthma. J Fam Pract 2003;52(7):520-522. (Pubitemid 36859113)
89. Rodrigo GJ, Rodrigo C, Pollack CV, Rowe B. Use of helium-oxygen mixtures in the treatment of acute asthma: a systematic review. Chest 2003;123(3):891-896. (Pubitemid 36315508)
90. Ram FS, Wellington S, Rowe B, Wedzicha JA. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev 2005;(1):CD004360.
91. Fernández MM, Villagrá A, Blanch L, Fernández R. Non-invasive mechanical ventilation in status asthmaticus. Intensive Care Med 2001;27(3):486-492. (Pubitemid 32250077)
92. Meduri GU, Turner RE, Abou-Shala N, Wunderink R, Tolley E. Noninvasive positive pressure ventilation via face mask. First-line intervention in patients with acute hypercapnic and hypoxemic respiratory failure. Chest 1996;109(1):179-193.
93. Garpestad E, Brennan J, Hill NS. Noninvasive ventilation for critical care. Chest 2007;132(2):711-720. (Pubitemid 47282412)
94. Beers SL, Abramo TJ, Bracken A, Wiebe RA. Bilevel positive airway pressure in the treatment of status asthmaticus in pediatrics. Am J Emerg Med 2007;25(1):6-9. (Pubitemid 44854369)
95. Soroksky A, Stav D, Shpirer I. A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. Chest 2003;123(4):1018-1025. (Pubitemid 36444356)
96. Blanch L, Bernabe F, Lucangelo U. Measurement of air trapping, intrinsic positive end-expiratory pressure, and dynamic hyperinflation in mechanically ventilated patients. Respir Care 2005;50(1):110-123. (Pubitemid 46190348)
97. Tuxen DV. Permissive hypercapnic ventilation. Am J Respir Crit Care Med 1994;150(3):870-874. (Pubitemid 24291523)
98. MacIntyre NR, Branson RD (editors). Mechanical ventilation. Philadelphia: WB Saunders; 2001.
99. Oddo M, Feihl F, Schaller MD, Perret C. Management of mechanical ventilation in acute severe asthma: Practical aspects. Intensive Care Med 2006;32(4):501-510.
100. Ni Chonghaile M, Higgins B, Laffey LG. Permissive hypercapnia: role in protective lung ventilatory strategies. Curr Opin Crit Care 2005;11(1):56-62. (Pubitemid 40223720)
101. Papiris S, Kotanidou A, Malagari K, Roussos C. Clinical review: Severe asthma. Crit Care, 2002;6(1):30-44. (Pubitemid 34162856)
102. Baigel, G. Volatile agents to avoid ventilating asthmatics. Anaesth Intensive Care 2003;31(2):208-210. (Pubitemid 36503837)
103. Padkin AJ, Baigel G, Morgan GA. Halothane treatment of severe asthma to avoid mechanical ventilation. Anaesthesia 1997;52(10):994-997. (Pubitemid 27455516)
104. Restrepo RD, Pettignano R, DeMeuse P. Halothane, an effective infrequently used drug, in the treatment of pediatric status asthmaticus: a case report. J Asthma 2005;42(8):649-651. (Pubitemid 41609531)
105. L'Hommedieu CS, Arens JJ. The use of ketamine for the emergency intubation of patients with status asthmaticus. Ann Emerg Med 1987;16(5):568-571. (Pubitemid 17064376)
106. Afessa B, Morales I, Cury JD. Clinical course and outcome of patients admitted to an ICU for status asthmaticus. Chest 2001;120(5):1616-1621. (Pubitemid 33078481)